Loading clinical trials...
Loading clinical trials...
Multicenter, Post-Market Study to Assess Outcomes of Patients Treated With the AFX System Compared to Other EVAR Devices for Endovascular Abdominal Aortic Aneurysm Repair: LEOPARD
Conditions
Interventions
AFX EVAR AAA Graft System
FDA Approved EVAR AAA Graft Systems
Locations
56
United States
Eliza Coffee Medical Center
Florence, Alabama, United States
Huntsville Hospital
Huntsville, Alabama, United States
Banner Good Samaritan Hospital
Phoenix, Arizona, United States
Carondelet Heart and Vascular Institute
Tucson, Arizona, United States
Central Arkansas Veteran's Healthcare System
Little Rock, Arkansas, United States
Long Beach VA Hospital
Long Beach, California, United States
Start Date
March 1, 2015
Primary Completion Date
October 1, 2018
Completion Date
October 1, 2022
Last Updated
October 1, 2024
NCT07473102
NCT04246463
NCT06218875
NCT02089607
NCT07020611
NCT07184723
Lead Sponsor
Endologix
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions